Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 140 Monotherapy Substitution in HIV-1
NCT02175680Phase 2Completed
- Sponsor
- CytoDyn Inc.
- Start
- Apr 2014
- Primary completion
- Feb 2015
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of leronlimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by CytoDyn Inc.. Started Apr 2014; status: completed.
02
Drugs
leronlimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02175680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175680.